Altogether, our results support that combined silencing of PANK4 and TMZ treatment significantly impede proliferation of drug‐resistant GBM cells, further emphasizing the chemo‐sensitizing potential of PANK4 depletion. The gene discussed is PANK4; the disease is glioblastoma.